Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Expression of HuR and Cyclooxygenase-2 in Nodular Fasciitis and Low- Grade Sarcoma: An Immunohistochemical Study

´ëÇѺ´¸®ÇÐȸÁö 2014³â 48±Ç 4È£ p.270 ~ 275
¼ÕÇöÁø, ¹éÅÂÈ­, À̽ÂÀ±, ±èÁÖÇå, °­µ¿¿í, ÀÌÇý°æ, ¹Ú¹ÌÀÚ,
¼Ò¼Ó »ó¼¼Á¤º¸
¼ÕÇöÁø ( Son Hyun-Jin ) 
Eulji University School of Medicine Department of Pathology

¹éÅÂÈ­ ( Baek Tae-Hwa ) 
Eulji University School of Medicine Department of Pathology
À̽ÂÀ± ( Lee Seung-Yun ) 
Eulji University School of Medicine Department of Pathology
±èÁÖÇå ( Kim Joo-Heon ) 
Eulji University School of Medicine Department of Pathology
°­µ¿¿í ( Kang Dong-Wook ) 
Eulji University School of Medicine Department of Pathology
ÀÌÇý°æ ( Lee Hye-Kyung ) 
Eulji University School of Medicine Department of Pathology
¹Ú¹ÌÀÚ ( Park Mee-Ja ) 
Eulji University School of Medicine Department of Pathology

Abstract


Background: Nodular fasciitis is the most common reactive mesenchymal lesion to be misidentified as a type of sarcoma. HuR is an mRNA-binding protein that can stabilize cyclooxygenase-2 (COX-2) mRNA leading to COX-2 overexpression. The aim of this study is a comparison of the expressions of COX-2 and HuR and the relationships between their expressions and the clinicopathological parameters in nodular fasciitis and low-grade sarcoma.

Methods: We measured the expression of HuR and COX-2 in 21 cases of nodular fasciitis and 37 cases of low-grade sarcoma using immunohistochemistry.

Results: The frequency of cytoplasmic immunoreactivity for HuR was 5 of 21 cases of nodular fasciitis (23.8%) and 23 of 37 cases of low-grade sarcoma (62.1%) (p=.013). COX-2 expression was moderate or strong in nodular fasciitis (12/21, 57.1%) and in low-grade sarcoma (29/37, 78.4%) (p=.034). In addition, a significant difference existed between these two entities in terms of the relationship between moderate or strong COX-2 expression and HuR cytoplasmic immunoreactivity (p=.009). Moderate or strong COX-2 immunoreactivity correlated with nuclear (p=.016) or cytoplasmic HuR (p=.024) expression in low-grade sarcoma but not in nodular fasciitis.

Conclusions: This study suggests that HuR and COX-2 expression may be useful to differentiate nodular fasciitis from low-grade sarcoma.

Å°¿öµå

Nodular fasciitis; Sarcoma; Cyclooxygenase 2; HuR; Immunohistochemistry

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS